Changes of lactate, glucose, ionized calcium and glutamate concentrations in cephalic vein blood during brain hypothermia using extracorporeal membrane oxygenation (ECMO) in a newborn infant with hypoxic-ischemic encephalopathy

2005 ◽  
Vol 33 (4) ◽  
Author(s):  
Kosuke Kobayashi ◽  
Satoshi Ibara ◽  
Masahiro Kusumoto ◽  
Hideki Maruyama ◽  
Eiji Kato ◽  
...  
Perfusion ◽  
2019 ◽  
Vol 34 (5) ◽  
pp. 433-436 ◽  
Author(s):  
Pavla Pokorná ◽  
Martin Šíma ◽  
Václav Vobruba ◽  
Martina Bašková ◽  
Lenka Posch ◽  
...  

Introduction: Sufentanil is a potent analgesic drug used for pain management. A few studies describe the pharmacokinetics of sufentanil in neonates; however, no pharmacokinetic data about sufentanil during extracorporeal membrane oxygenation have been published yet. Case report: A 1-day-old neonate with moderate hypoxic–ischemic encephalopathy received veno-arterial extracorporeal membrane oxygenation support for refractory respiratory and circulatory failure. Sufentanil plasma concentrations were determined during both extracorporeal membrane oxygenation (n = 14) and non–extracorporeal membrane oxygenation (n = 17) period. Based on these measurements, individual sufentanil pharmacokinetic parameters were calculated. Discussion: We observed increased sufentanil volume of distribution (11.6 vs 5.6 L/kg) and decreased sufentanil clearance (0.535 vs 0.746 L/h/kg) in extracorporeal membrane oxygenation period. The increment of volume of distribution was attributed to ECMO influence, while difference in clearance was probably due to drug interaction. Conclusions: This is the first description of sufentanil pharmacokinetics in neonate treated with extracorporeal membrane oxygenation. We observed considerably larger volume of distribution during extracorporeal membrane oxygenation period in comparison with non–extracorporeal membrane oxygenation period.


2007 ◽  
Vol 83 (4) ◽  
pp. 217-223 ◽  
Author(s):  
Marie Horan ◽  
A. David Edwards ◽  
Richard K. Firmin ◽  
Tiena Ablett ◽  
Hilary Rawson ◽  
...  

1991 ◽  
Vol 118 (3) ◽  
pp. 431-436 ◽  
Author(s):  
Thomas R. Kimball ◽  
Stephen R. Daniels ◽  
Richard G. Weiss ◽  
Richard A. Meyer ◽  
David W. Hannon ◽  
...  

1989 ◽  
Vol 4 (1_suppl) ◽  
pp. S52-S61 ◽  
Author(s):  
Aurelio Matamoros ◽  
Joseph C. Anderson ◽  
James McConnell ◽  
David L. Bolam

Extracorporeal membrane oxygenation (ECMO) is an approved therapy for some neonates who have respiratory failure that is due to hyaline membrane disease, meconium aspiration, persistent pulmonary hypertension, congenital diaphragmatic hernia, or sepsis. The major complication of this therapy is hemorrhage, with intracranial hemorrhage having the highest morbidity and mortality. Seizures, incisional bleeding and bleeding in the pleural space, hypoxic-ischemic encephalopathy, renal failure, and cardiovascular complications account for most of the other complications. Cranial sonography provides an ideal imaging modality for baseline evaluation and daily follow-up; however, computed tomography and magnetic resonance imaging, because of better sensitivity, are important for assessment after ECMO. The changes in intracranial blood flow related to ECMO can be noninvasively evaluated by Doppler ultrasound modalities. (J Child Neurol 1989;4:S52-S61).


Sign in / Sign up

Export Citation Format

Share Document